About Rubicon Genomics
Rubicon Genomics is a company based in Ann Arbor (United States) founded in 2000 was acquired by Takara Bio in December 2016.. Rubicon Genomics has raised $13.04 million across 6 funding rounds from investors including Takara Bio, Broadoak Capital Partners and Research Corporation Technologies. The company has 33 employees as of December 31, 2018. Rubicon Genomics operates in a competitive market with competitors including RareCyte, Sequenta, seqWell, Paragon Genomics and Neogen, among others.
- Headquarter Ann Arbor, United States
- Employees 33 as on 31 Dec, 2018
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rubicon Genomics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.04 M (USD)
in 6 rounds
-
Latest Funding Round
$2 M (USD), Series B
Jul 15, 2015
-
Investors
Takara Bio
& 2 more
-
Employee Count
33
as on Dec 31, 2018
-
Acquired by
Takara Bio
(Dec 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Rubicon Genomics
Rubicon Genomics has successfully raised a total of $13.04M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $2.0M
-
First Round
First Round
(29 Mar 2004)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Series B - Rubicon Genomics | Valuation |
investors |
|
| Nov, 2007 | Amount | Series B - Rubicon Genomics | Valuation |
investors |
|
| Jun, 2005 | Amount | Series A - Rubicon Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rubicon Genomics
Rubicon Genomics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Takara Bio, Broadoak Capital Partners and Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location | |
|
Investment banking services are offered in the United States.
|
Founded Year | Domain | Location | |
|
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rubicon Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rubicon Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rubicon Genomics Comparisons
Competitors of Rubicon Genomics
Rubicon Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as RareCyte, Sequenta, seqWell, Paragon Genomics and Neogen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Immuno-sequencing products are developed for disease diagnostics and treatment.
|
|
| domain | founded_year | HQ Location |
NGS-based reagents and kits are supplied for life sciences research.
|
|
| domain | founded_year | HQ Location |
Provider of technologies and solutions genomic research and precision medicine
|
|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and services are supplied to biotech industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rubicon Genomics
Frequently Asked Questions about Rubicon Genomics
When was Rubicon Genomics founded?
Rubicon Genomics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Where is Rubicon Genomics located?
Rubicon Genomics is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Is Rubicon Genomics a funded company?
Rubicon Genomics is a funded company, having raised a total of $13.04M across 6 funding rounds to date. The company's 1st funding round was a Series A of $1.11M, raised on Mar 29, 2004.
How many employees does Rubicon Genomics have?
As of Dec 31, 2018, the latest employee count at Rubicon Genomics is 33.
What does Rubicon Genomics do?
Rubicon Genomics was founded in 2000 and is based in Ann Arbor, United States. Operations focus on the biotechnology sector, where reagents and kits for pre-analytical amplification technologies are developed. Three kits are offered for use with Illumina next-generation sequencing systems, while two kits support microarray and PCR applications. These products facilitate sample preparation in genomic research environments.
Who are the top competitors of Rubicon Genomics?
Rubicon Genomics's top competitors include Neogen, Paragon Genomics and Biotangents.
Who are Rubicon Genomics's investors?
Rubicon Genomics has 3 investors. Key investors include Takara Bio, Broadoak Capital Partners, and Research Corporation Technologies.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.